Alpha 2.0
Login Register
» Articles » PMID: 33012270

Toll-Like Receptor Antagonists As a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients

Overview
Journal Viral Immunol
Specialties Allergy & Immunology
Microbiology
Date 2020 Oct 5
PMID 33012270
Citations 7
Authors
Sadegh Safaei
Masoud Karimi-Googheri
Affiliations
Soon will be listed here.
Citing Articles

Novel Therapeutic Target Critical for SARS-CoV-2 Infectivity and Induction of the Cytokine Release Syndrome.

Harless W, Lewis B, Qorri B, Abdulkhalek S, Szewczuk M Cells. 2023; 12(9).

PMID: 37174732 PMC: 10177205. DOI: 10.3390/cells12091332.

Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond.

Faist A, Janowski J, Kumar S, Hinse S, Caliskan D, Lange J Cells. 2022; 11(14).

PMID: 35883640 PMC: 9316821. DOI: 10.3390/cells11142198.

COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by gene polymorphism (rs3853839) in middle-aged individuals without previous comorbidities.

El-Hefnawy S, Eid H, Mostafa R, Soliman S, Omar T, Azmy R Gene Rep. 2022; 27:101612.

PMID: 35463461 PMC: 9013694. DOI: 10.1016/j.genrep.2022.101612.

Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19.

Khalifa A, Ghoneim A Curr Res Pharmacol Drug Discov. 2021; 2:100068.

PMID: 34870161 PMC: 8562070. DOI: 10.1016/j.crphar.2021.100068.

Why Females Do Better: The X Chromosomal TLR7 Gene-Dose Effect in COVID-19.

Spiering A, de Vries T Front Immunol. 2021; 12:756262.

PMID: 34858409 PMC: 8632002. DOI: 10.3389/fimmu.2021.756262.